Sfoglia per Autore
Minimal laboratory investigation of uremic patients.
1985 D. Brancaccio, A. Minetti, E. Sabbioni, R. Pietra, O. Bugiani, G. Como, M. Gallieni
Insulin resistance in uremia: in vitro model in the rat liver using human serum to study mechanisms
1986 F. Folli, M.K. Sinha, D. Brancaccio, J.F. Caro
Desferrioxamine infusion test
1987 P. Gilli, F. Malacarne, A. Storari, D. Brancaccio, M. Gallieni, M. Andriani, A. Piccoli, M. Nordio
Aluminum-dependent transfusions in dialysis
1988 D. Brancaccio, M. Gallieni, A. Anelli, P. Padovese
Dialysis amyloidosis with massive popliteal deposition of beta 2-microglobulin amyloid
1988 D. Brancaccio, M.A. Gallieni, P. Padovese, A. Anelli, G. Coggi, C.M. Uslenghi
Beta-2-microglobulin amyloidosis and osteo-articular pathology of the uremic patient on regular dialysis
1990 D. Brancaccio, A. Anelli, M. Gallieni, P. Padovese, G. Coggi, C. Uslenghi
Desferrioxamine infusion can modify EEG tracing in haemodialysed patients
1991 D. Brancaccio, G. Avanzini, P. Padovese, M. Gallieni, S. Franceschetti, F. Panzica, A. Anelli, G. Colantonio, D. Martinelli, O. Bugiani
Ingrandimento delle ghiandole salivari da mezzo di contrasto iodato endovenoso. Descrizione di un caso
1991 F. Gattoni, C. Pozzato, P. Padovese, A.M. Rizzi, D. Brancaccio, C. Uslenghi
Subcondropatie del ginocchio nei dializzati cronici
1991 A. Surace, L. Pietrogrande, F. Mapelli Mozzi, G. Tandoi, A. Anelli, D. Brancaccio, P. Braidotti, G. Coggi
Which is the preferred treatment of advanced hyperparathyroidism in a renal patient? I. Medical intervention is the primary option in the treatment of advanced hyperparathyroidism in chronic renal failure
1994 M. Gallieni, D. Brancaccio
Recent advances in intravenous calcitriol treatment
1994 D. Brancaccio, M. Gallieni
Vitamin D metabolism in chronic renal failure
1995 M. Gallieni, M. Cozzolino, D. Brancaccio
Effect of gastric acid secretion on intestinal phosphate and calcium absorption in normal subjects
1995 G. Graziani, G. Como, S. Badalamenti, S. Finazzi, A. Malesci, M. Gallieni, D. Brancaccio, C. Ponticelli
Deposition of kappa and lambda light chains in amyloid filaments of dialysis-related amyloidosis
1995 D. Brancaccio, G.M. Ghiggeri, P. Braidotti, A. Garberi, M. Gallieni, V. Bellotti, U. Zoni, R. Gusmano, G. Coggi
Dialysis amyloidosis : clinical aspects and therapeutic approach
1996 D. Brancaccio, M. Cozzolino, M. Gallieni
Treatment of hyperparathyroidism-why is it crucial to control serum phosphate?
1996 D. Brancaccio, M. Gallieni, M. Cozzolino
Trace elements in renal failure: are they clinically important?
1996 M. Gallieni, D. Brancaccio, M. Cozzolino, E. Sabbioni
ACE-inhibitors and progression of chronic renal insufficiency : a contribution of Italian clinical research
1998 V.E. Andreucci, M.A. Gallieni, D. Brancaccio
Bone geometry, biomechanics, and mineral content of the distal radius in uremic patients with severe hyperparathyroidism =[Valutazione delle proprietà geometriche, biomeccaniche e osteodensitometriche del radio ultradistale mediante Tomografia Computerizzata quantitativa periferica nei pazienti uremici affetti da iperparatiroidismo grave
1999 C. Di Leo, G. Tarolo, A. Bestetti, L. Tagliabue, A. Del Sole, G. Aliberti, A. Ardemagni, M. Gallieni, D. Brancaccio, W. Froehlich
Effects of a vitamin E-modified dialyzer (Excebrane) on beta-2-microglobulin structure and removal
1999 D. Brancaccio, V. Bellotti, B. Losi, P. Padovese, M. Cozzolino, P. Carpani, P. Mangione, S. Giorgetti, M. Gallieni
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile